Company ICU Medical, Inc.

Equities

ICUI

US44930G1076

Medical Equipment, Supplies & Distribution

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Group companies

Sector

Sales per Business

Sales per region

Ratings for ICU Medical, Inc.

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX Other stock markets 03:45:23 2024-04-19 pm EDT			5-day change	1st Jan Change
95.63 ^USD	-1.31%		-2.19%	-3.70%

Mar. 20	Transcript : ICU Medical, Inc. Presents at KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum, Mar-20-2024 02:15 PM
Mar. 15	Icu Medical Inc/de Insider Sold Shares Worth $812,741, According to a Recent SEC Filing	MT

ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needle free IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy product include Portex BLUselect PVC tracheostomy tubes.

Number of employees: 14,000

USD in Million	2022	Weight	2023	Weight	Delta
Consumables 42.9 %	-	-	969	42.9 %	-
Vital Care 29.3 %	-	-	661	29.3 %	-
Infusion Systems 27.8 %	351	15.4 %	629	27.8 %	+79.17%

USD in Million	2022	Weight	2023	Weight	Delta
United States 63.7 %	1,460	64.0 %	1,440	63.7 %	-1.37%
Europe, the Middle East and Africa 16.5 %	367	16.1 %	374	16.5 %	+1.68%
Asia-Pacific 10.7 %	257	11.3 %	242	10.7 %	-6.03%
Other Foreign 9.0 %	195	8.6 %	204	9.0 %	+4.37%

Managers	Title	Age	Since
Vivek Jain CEO	Chief Executive Officer	52	14-02-12
George Lopez FOU	Founder	76	83-12-31
Brian Bonnell DFI	Director of Finance/CFO	50	18-04-30
Krishna Uppugonduri CTO	Chief Tech/Sci/R&D Officer	-	15-02-28
Christian Voigtlander COO	Chief Operating Officer	56	17-01-31
Thomas D. McCall IRO	Public Communications Contact	66	10-06-30
Daniel Woolson PRN	Corporate Officer/Principal	47	16-12-31
Virginia Sanzone LAW	General Counsel	49	15-07-31

Members of the board	Title	Age	Since
George Lopez FOU	Founder	76	83-12-31
David Hoffmeister BRD	Director/Board Member	69	18-01-04
Kolleen Kennedy BRD	Director/Board Member	63	21-12-30
Vivek Jain CEO	Chief Executive Officer	52	14-02-12
Elisha Finney BRD	Director/Board Member	62	16-01-07
Donald Abbey BRD	Director/Board Member	57	18-01-04
David C. Greenberg BRD	Director/Board Member	57	15-06-14
Laurie Hernandez BRD	Director/Board Member	66	21-06-30

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	24,367,510	21,231,963 ( 87.13 %)	2,428 ( 0.009964 %)	87.13 %

Name	Equities	%	Valuation
Janus Henderson Investors US LLC 10.84 %	2,617,933	10.84 %	281 M $
BlackRock Advisors LLC 10.29 %	2,483,065	10.29 %	266 M $
Vanguard Fiduciary Trust Co. 10.11 %	2,440,729	10.11 %	262 M $
SMITHS GROUP PLC 6.917 %	1,670,000	6.917 %	179 M $
Wellington Management Co. LLP 6.526 %	1,575,456	6.526 %	169 M $
Fuller & Thaler Asset Management, Inc. 6.097 %	1,472,050	6.097 %	158 M $
George Lopez 4.950 %	1,195,096	4.950 %	128 M $
JPMorgan Investment Management, Inc. 3.061 %	738,892	3.061 %	79 M $
STATE STREET CORPORATION 2.998 %	723,682	2.998 %	78 M $
Eaton Vance Management 2.422 %	584,633	2.422 %	63 M $

ICU Medical, Inc.

951 Calle Amanecer

92673-6212, San Clemente

+949 366 2183

http://www.icumed.com

Name	Category and Sector
Smiths Medical ASD, Inc. Smiths Medical ASD, Inc. Medical SpecialtiesHealth Technology Smiths Medical ASD, Inc. manufactures and distributes medical devices. Its products include tracheal tube introducers and guides, pleural catheter with flexible introducer, CADD-solid ambulatory infusion pump, MEDEX accessories, continuous caudal and pediatric epidural trays, SPECTRO2 30 pulse oximeter, C-fuser pressure infuser, and coach 2 incentive spirometer. The firm specialty care areas include adult critical care, cardiology, emergency medicine, general anesthesia, homecare, oncology, and pain management. The company was founded by S. A. Leader in 1940 and is headquartered in Minneapolis, MN.	Medical Specialties

Name

Category and Sector

Medical Specialties

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

96.9 USD

Average target price

142.2 USD

Spread / Average Target

+46.80%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ICU MEDICAL, INC.	-2.03%	2.36B
ABBOTT LABORATORIES	-2.59%	183B
MEDTRONIC PLC	-3.51%	105B
DEXCOM, INC.	+7.48%	51.77B
CENCORA, INC.	+15.93%	47.29B
HOYA CORPORATION	-1.73%	40.2B
WEST PHARMACEUTICAL SERVICES, INC.	+7.16%	27.62B
METTLER-TOLEDO INTERNATIONAL, INC.	-1.61%	25.51B
TERUMO CORPORATION	+9.84%	24.73B
ZIMMER BIOMET HOLDINGS, INC.	-1.82%	24.52B

Other Medical Equipment, Supplies & Distribution